Skip to main content
. 2009 Jul 13;587(Pt 17):4249–4264. doi: 10.1113/jphysiol.2009.175349

Table 1.

Solutions

Extracellular NaCl KCl NaH2PO4 NaHCO3 Hepes CsCl TEA-Cl CaCl2 MgCl2 Sucrose Glucose NMDG-Cl or TEA-CL or LiCl
Cutting 1 26 1 9 248 10
ACSF 125 2.5 1.25 25 2 2 10
ExTNM 26 10 10 112 0 or 0.5 4 11
ExTNM Na+ subst. 10 10 112 0.5 4 11 26
ExTNM + 2 K+ 26 2 10 10 112 0.5 4 11
ExTNM Na+
subst. + 2 K+ 2 10 10 112 0.5 4 11 26

Intracellular Potassium gluconate KCl CsCl Hepes EGTA MgCl2 Tris-GTP Mg-ATP Sodium phosphocr.

CsCl 133 10 10 2 0.4 4 10
Pot gluc 110 20 10 10 2 0.4 4 10
CsCl + KCl 20 113 10 10 2 0.4 4 10

Concentrations are indicated in mmol l−1. In voltage clamp experiments, the following blockers were routinely added to ExTNM and ExTNM Na+ subst : TTX (1 μm), nifedipin (10 μm), mibefradil (10 μm). Flufenamic acid (10 μm) was added for n= 14 recordings as indicated. All intracellular solutions were added with 4 MgATP, 0.4 Tris-GTP and 10 Na2-phosphocreatine (in mm). The pH of intracellular solutions was adjusted to 7.3 with KOH for the potassium gluconate-based solution and CsOH for the CsCl-based solution.